Table 3 Putatively causal rare (PIP > 0.05 and non-Finnish EUR MAF < 0.01) variants significantly associated at the study-wide level (P < 1 × 10−8) with the risk of prostate cancer
Gene | Protein Change | Variant (Chr:Pos:ref:alt, HGVS) | P | OR [95% CI] | MAF (non-Finnish EUR) | MAF (Finnish Eur) | PIP |
---|---|---|---|---|---|---|---|
HOXB13 | ENST00000290295:p.Gly84Glu | 17:48728343:C:T, NC_000017.11:g.48728343C>T | 1.95 × 10−181 | 4.69 [4.22–5.21] | 0.00244 | 0.00786 | 1 |
ANO7 | ENST00000274979:p.Glu226Lys | 2:241200185:G:A, NC_000002.12:g.241200185G>C | 4.57 × 10−26 | 0.699 [0.659–0.741] | 0.00793 | 0.0619 | 0.985 |
CHEK2 | ENST00000328354:p.Thr367fs | 22:28695868:AG:A, NC_000022.11:g.28695869del | 1.17 × 10−20 | 1.67 [1.46–1.91] | 0.00255 | 0.00861 | 0.078 |
SPDL1 | ENST00000265295:p.Arg20Gln | 5:169588475:G:A, NC_000005.10:g.169588475G>A | 3.06 × 10−13 | 0.718 [0.663–0.777] | 0.00679 | 0.0346 | 0.996 |
AR | ENST00000374690:p.Glu654Lys | X:67711476:G:A, NC_000023.11:g.67711476G>A | 1.28 × 10−11 | 0.706 [0.655–0.761] | 6.90 × 10−4 | 0.0194 | 0.604 |
BIK | ENST00000216115:p.Ala139_ Leu148del | 22:43129228: GTGCTGCTGGCGCTGCTGCTGCTGCTGGCGC:G, NC_000022.11:g. 43129228del | 2.04 × 10−11 | 2.08 [1.68–2.57] | 1.94 × 10−4 | 0.00331 | 0.3 |
TERT | ENST00000310581:p.Asp684Gly | 5:1279370:T:C, NC_000005.10:g.1279370T>C | 4.67 × 10−10 | 0.134 [0.071–0.252] | 1.5 × 10−5 | 0.00151 | 0.985 |